Samarth Kulkarni - Dec 24, 2024 Form 4 Insider Report for CRISPR Therapeutics AG (CRSP)

Role: Chief Executive Officer, Director
Signature: /s/ Elizabeth Ryland Waldinger, attorney-in-fact
Stock symbol: CRSP
Transactions as of: Dec 24, 2024
Transactions value $: $222,904
Form type: 4
Date filed: 12/27/2024, 05:35 PM
Previous filing: Dec 4, 2024
Next filing: Feb 19, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRSP	Common Shares	Options Exercise	$223K	+13.8K	+7.57%	$16.21	195K	Dec 24, 2024	Direct
holding	CRSP	Common Shares						85.6K	Dec 24, 2024	The Kulkarni 2023 GRAT

Showing 1 to 2 of 2 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRSP	Stock Option (Right to Buy)	Options Exercise	$0	-13.8K	-100%	$0.00	0	Dec 24, 2024	Common Shares	13.8K	$16.21	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted on May 3, 2017 with respect to 100,000 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning May 31, 2017.